Unusual toxicities with TNF inhibition: Heart failure and drug-induced lupus

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Serious and unexpected adverse events, such as heart failure and drug-induced lupus, have been reported in patients receiving TNF inhibitor therapy. These events generally are easily recognizable, although they cannot be predicted nor avoided, other than by drug avoidance altogether. Many patients have great benefit from anti-TNF therapies. Their intelligent use requires a firm understanding of these rare toxicities, so as to minimize the morbidity associated with their uncommon occurrence.

Original languageEnglish (US)
Pages (from-to)S141-S147
JournalClinical and experimental rheumatology
Volume22
Issue number5 SUPPL. 35
StatePublished - Oct 18 2004
Externally publishedYes

Fingerprint

Heart Failure
Pharmaceutical Preparations
Morbidity
Therapeutics

Keywords

  • Congestive heart failure
  • Drug-induced lupus
  • Rheumatoid arthritis
  • TNF inhibitors

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Unusual toxicities with TNF inhibition : Heart failure and drug-induced lupus. / Cush, John J.

In: Clinical and experimental rheumatology, Vol. 22, No. 5 SUPPL. 35, 18.10.2004, p. S141-S147.

Research output: Contribution to journalArticle

@article{3649657ddd874307ac677365a608936f,
title = "Unusual toxicities with TNF inhibition: Heart failure and drug-induced lupus",
abstract = "Serious and unexpected adverse events, such as heart failure and drug-induced lupus, have been reported in patients receiving TNF inhibitor therapy. These events generally are easily recognizable, although they cannot be predicted nor avoided, other than by drug avoidance altogether. Many patients have great benefit from anti-TNF therapies. Their intelligent use requires a firm understanding of these rare toxicities, so as to minimize the morbidity associated with their uncommon occurrence.",
keywords = "Congestive heart failure, Drug-induced lupus, Rheumatoid arthritis, TNF inhibitors",
author = "Cush, {John J.}",
year = "2004",
month = "10",
day = "18",
language = "English (US)",
volume = "22",
pages = "S141--S147",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "5 SUPPL. 35",

}

TY - JOUR

T1 - Unusual toxicities with TNF inhibition

T2 - Heart failure and drug-induced lupus

AU - Cush, John J.

PY - 2004/10/18

Y1 - 2004/10/18

N2 - Serious and unexpected adverse events, such as heart failure and drug-induced lupus, have been reported in patients receiving TNF inhibitor therapy. These events generally are easily recognizable, although they cannot be predicted nor avoided, other than by drug avoidance altogether. Many patients have great benefit from anti-TNF therapies. Their intelligent use requires a firm understanding of these rare toxicities, so as to minimize the morbidity associated with their uncommon occurrence.

AB - Serious and unexpected adverse events, such as heart failure and drug-induced lupus, have been reported in patients receiving TNF inhibitor therapy. These events generally are easily recognizable, although they cannot be predicted nor avoided, other than by drug avoidance altogether. Many patients have great benefit from anti-TNF therapies. Their intelligent use requires a firm understanding of these rare toxicities, so as to minimize the morbidity associated with their uncommon occurrence.

KW - Congestive heart failure

KW - Drug-induced lupus

KW - Rheumatoid arthritis

KW - TNF inhibitors

UR - http://www.scopus.com/inward/record.url?scp=4944223125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4944223125&partnerID=8YFLogxK

M3 - Article

C2 - 15552528

AN - SCOPUS:4944223125

VL - 22

SP - S141-S147

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 5 SUPPL. 35

ER -